SLC25家族的基本特征及其在肿瘤中的作用

摘要/Abstract

摘要：人溶质载体蛋白25家族是人溶质载体蛋白家族中的一个超家族，该家族成员通过跨线粒体膜转运各种溶质从而发挥作用。线粒体载体在转运底物的性质和大小、运输方式等方面差异很大，并且参与细胞的多种生理过程。越来越多的研究发现，该家族成员在肿瘤中异常表达，且部分成员在肿瘤的发生和发展中起到了一定的作用，如通过调节细胞代谢、死亡、增殖从而参与肿瘤发生、发展过程。

程思维，胡君，熊伍军. SLC25家族的基本特征及其在肿瘤中的作用[J]. 国际肿瘤学杂志, 2018, 45(8): 548-551.

Cheng Siwei, Hu Jun, Xiong Wujun. Essential characteristics and functions of SLC25 family in tumor[J]. Journal of International Oncology, 2018, 45(8): 548-551.

［1］ Palmieri F. The mitochondrial transporter family SLC25: identification, properties and physiopathology［J］. Mol Aspects Med, 2013, 34(23): 465484. DOI: 10.1016/j.mam.2012.05.005. ［2］ Schlessinger A, Khuri N, Giacomini KM, et al. Molecular modeling and ligand docking for solute carrier (SLC) transporters［J］. Curr Top Med Chem, 2013, 13(7): 843856. ［3］ Wang YJ, Khan FI, Xu Q, et al. Recent studies of mitochondrial SLC25: integration of experimental and computational approaches［J］. Curr Protein Pept Sci, 2018, 19(5): 507522. DOI: 10.2174/1389203718666161108095052. ［4］ Palmieri F, Pierri CL, De Grassi A, et al. Evolution, structure and function of mitochondrial carriers: a review with new insights［J］. Plant J, 2011, 66(1): 161181. DOI: 10.1111/j.1365313X.2011.04516.x. ［5］ GutiérrezAguilar M, Baines CP. Physiological and pathological roles of mitochondrial SLC25 carriers［J］. Biochem J, 2013, 454(3): 371386. DOI: 10.1042/BJ20121753. ［6］ Poncet D, Pauleau AL, Szabadkai G, et al. Cytopathic effects of the cytomegalovirusencoded apoptosis inhibitory protein vMIA［J］. J Cell Biol, 2006, 174(7): 985996. DOI: 10.1083/jcb.200604069. ［7］ Wilkins HM, Marquardt K, Lash LH, et al. Bcl2 is a novel interacting partner for the 2oxoglutarate carrier and a key regulator of mitochondrial glutathione［J］. Free Radic Biol Med, 2012, 52(2): 410419. DOI: 10.1016/j.freeradbiomed.2011.10.495. ［8］ Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation［J］. Cell, 2011, 144(5): 646674. DOI: 10.1016/j.cell.2011.02.013. ［9］ Brix B, Mesters JR, Pellerin L, et al. Endothelial cellderived nitric oxide enhances aerobic glycolysis in astrocytes via HIF1αmediated target gene activation［J］. J Neurosci, 2012, 32(28): 97279735. DOI: 10.1523/JNEUROSCI.087912.2012. ［10］ Zhang H, Wang Q, Gu J, et al. Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondriaderived nitric oxide［J］. Oncogene, 2018, 37(19): 25452558. DOI: 10.1038/s413880180139x. ［11］ Baulies A, Montero J, Matías N, et al. The 2oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading［J］. Redox Biol, 2018, 14: 164177. DOI: 10.1016/j.redox.2017.08.022. ［12］ Traba J, Del Arco A, Duchen MR, et al. SCaMC1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADPmediated matrix Ca(2+) buffering［J］. Cell Death Differ, 2012, 19(4): 650660. DOI: 10.1038/cdd.2011.139. ［13］ Dalla Pozza E, Fiorini C, Dando I, et al. Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine［J］. Biochim Biophys Acta, 2012, 1823(10): 18561863. DOI: 10.1016/j.bbamcr.2012.06.007. ［14］ Sayeed A, Meng Z, Luciani G, et al. Negative regulation of UCP2 by TGFβ signaling characterizes low and intermediategrade primary breast cancer［J］. Cell Death Dis, 2010, 1: e53. DOI: 10.1038/cddis.2010.30. ［15］ Wong CC, Qian Y, Li X, et al. SLC25A22 promotes proliferation and survival of colorectal cancer cells with KRAS mutations and xenograft tumor progression in mice via intracellular synthesis of aspartate［J］. Gastroenterology, 2016, 151(5): 945960.e6. DOI: 10.1053/j.gastro.2016.07.011. ［16］ Xie J, Zhu XY, Liu LM, et al. Solute carrier transporters: potential targets for digestive system neoplasms［J］. Cancer Manag Res, 2018, 10: 153166. DOI: 10.2147/CMAR.S152951. ［17］ CatalinaRodriguez O, Kolukula VK, Tomita Y, et al. The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis［J］. Oncotarget, 2012, 3(10): 12201235. DOI: 10.18632/oncotarget.714. ［18］ Cheng L, Lu W, Kulkarni B, et al. Analysis of chemotherapy response programs in ovarian cancers by the nextgeneration sequencing technologies［J］. Gynecol Oncol, 2010, 117(2): 159169. DOI: 10.1016/j.ygyno.2010.01.041. ［19］ Favre C, Zhdanov A, Leahy M, et al. Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells［J］. Oncogene, 2010, 29(27): 39643976. DOI: 10.1038/onc.2010.146. ［20］吕依宣, 王晓娜, 吴金亮, 等. 线粒体二羧基载体蛋白SLC25A10对脑胶质瘤细胞增殖的影响及机制［J］. 上海交通大学学报(医学版), 2016, 36(11): 15811587, 1593. DOI: 10.3969/j.issn.16748115.2016.11.008. ［21］蔺媛媛. SLC25A10抑制肝癌凋亡的作用及机制研究［D］. 大连, 大连医科大学, 2017. ［22］ Tina E, Lindqvist BM, Gabrielson M, et al. The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2positive breast tumors［J］. BMC Cancer, 2012, 12: 350. DOI: 10.1186/1471240712350. ［23］ Lindqvist BM, Farkas SA, Wingren S, et al. DNA methylation pattern of the SLC25A43 gene in breast cancer［J］. Epigenetics, 2012, 7(3): 300306. DOI: 10.4161/epi.7.3.19064. ［24］ Prosén S, Eremo AG, Tsegai AD, et al. Decreased expression of the mitochondrial solute carrier SLC25A43 in basal cell carcinoma compared with healthy skin［J］. Oncol Lett, 2017, 14(2): 22182222. DOI: 10.3892/ol.2017.6452. ［25］ Santandreu FM, Valle A, Fernández de Mattos S, et al. Hydrogen peroxide regulates the mitochondrial content of uncoupling protein 5 in colon cancer cells［J］. Cell Physiol Biochem, 2009, 24(56): 379390. DOI: 10.1159/000257430. ［26］ Gonidi M, Athanassiadou AM, Patsouris E, et al. Mitochondrial UCP4 and bcl2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors［J］. Pathol, Res Pract, 2011, 207(6): 377382. DOI: 10.1016/j.prp.2011.03.007. ［27］ Chevrollier A, Loiseau D, Reynier P, et al. Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism［J］. Biochim Biophys Acta, 2011, 1807(6): 562567. DOI: 10.1016/j.bbabio.2010.10.008. ［28］ Wilting SM, de Wilde J, Meijer CJ, et al. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer［J］. Genes Chromosomes Cancer, 2008, 47(10): 890905. DOI: 10.1002/gcc.20590.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.

SLC25家族的基本特征及其在肿瘤中的作用

Essential characteristics and functions of SLC25 family in tumor

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价